Obesity is a significant risk factor for prostate cancer at the time of biopsy. - Wikidata - awgldk - TriplyDB

Obesity is a significant risk factor for prostate cancer at the time of biopsy.

Obesity is a significant risk factor for prostate cancer at the time of biopsy.

http://www.wikidata.org/entity/Q35231117

about

Predictive value of digital rectal examination for prostate cancer detection is modified by obesity Body mass index affects the diagnosis and progression of prostate cancer in Hispanics Obesity affects the biopsy-mediated detection of prostate cancer, particularly high-grade prostate cancer: a dose-response meta-analysis of 29,464 patients.Obesity and eating habits among college students in Saudi Arabia: a cross sectional study Lifestyle as risk factor for cancer: Evidence from human studies.Handling difficult anastomosis. Tips and tricks in obese patients and narrow pelvis.Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.Leptin gene tetranucleotide repeat polymorphism in obese individuals in Egypt.A high-fat diet containing lard accelerates prostate cancer progression and reduces survival rate in mice: possible contribution of adipose tissue-derived cytokines Advantages of robot-assisted laparoscopic radical prostatectomy in obese patients: comparison with the open procedure.The Association Between Body Mass Index and Dental Caries: Cross-Sectional Study Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men.Urological aspects of the metabolic syndrome.The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?Prostate cancer cell proliferation and angiogenesis in different obese mice models.Is phytoestrogen intake associated with decreased risk of prostate cancer? A systematic review of epidemiological studies based on 17,546 cases.Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy.Body mass index influences prostate cancer risk at biopsy in Japanese men.Obesity is associated with higher risk of prostate cancer detection in a biopsy population in Korea.Metabolic risk factors in prostate cancer.Serum levels of sex hormone binding globulin (SHBG) are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort.[Metabolic syndrome and prostate cancer].Obesity-PSA relationship: a new formula.Influence of obesity on tumour volume in patients with prostate cancer.The Correlation between Body Mass Index and Routine Parameters in Men Over Fifty.Obesity does not influence prostate intrafractional motion.Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysis.Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancer.Deciphering Possible Association of Risk Factors for Dental Caries in Pakistani Population.

P2860

Q33778985-9CDAAB61-7486-4C12-825E-C42921FDC8F9 Q33894539-7268CBC1-0B77-4DAC-AAA1-D109AD541E5C Q34128835-137EE44E-05FF-4DB9-B7D9-15D234BB76B9 Q34174198-9540AF8B-95B5-487C-9B95-AC0EEB3FE511 Q34346770-3909D94C-D53E-4462-AD0E-B57AA901003D Q34453379-61E4915D-EC9A-453A-9C50-D1A1F64EB2A1 Q35100152-9828D64F-0CEA-4159-B552-04995B831316 Q35387666-9E88E750-FF49-45D6-961F-AB4858AC73D6 Q35585932-1EC2A547-E838-4271-9DD5-0A84E8A27CDF Q36189752-18B8F246-7DBC-41D7-B26D-C37B916D57AD Q36429749-6EB1FF52-97A4-4035-9109-D25946DA7D8A Q37059322-CF2AC5C9-499B-4B80-8491-8D358BB00479 Q37910709-3D03345C-A06F-47D1-8CD1-A79BFA376AD7 Q38211603-EE8CBEB4-3ED8-483A-B7DC-66120B670520 Q38342105-DE2532CD-4331-47A6-A460-7E8A9E2A7EF2 Q38853399-1A0194C4-7B4B-411D-82AD-C36541BEDF9A Q39972993-1A35693D-6D28-4002-900D-68E8357CCDEB Q40077148-061646A4-AD1F-4CCA-8A67-167EC9E6A675 Q40155962-90CA4F1B-BD1D-401F-A949-7090690A94D6 Q42759606-FB79CE0B-BFEE-44C9-85A1-6D3B6600807F Q43463703-70B28E39-E7F6-46D6-A208-100C36D42796 Q44396004-B64473FF-CADA-4FB0-8C96-FC983D504F1E Q46752212-593B0112-5ADC-4833-A9AA-D9145FB105A1 Q46770186-918B0273-119C-4E54-B048-5FFED5364E71 Q47156572-32011C77-9FB9-46F4-B401-C81F30F28F40 Q48186407-F7A5C8A3-044B-4304-AEC4-F8FE90C95D7D Q51295999-C33795C4-4FD4-464B-82BC-39C85EBCFC40 Q53273464-9FDC4F6C-2ACC-4308-8618-57307DB1B309 Q55384046-B1371A87-A011-4256-A1FC-51906864A0C7

P2860

Obesity is a significant risk factor for prostate cancer at the time of biopsy.

http://www.wikidata.org/entity/Q35231117

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Obesity is a significant risk factor for prostate cancer at the time of biopsy.

@ast

Obesity is a significant risk factor for prostate cancer at the time of biopsy.

@en

type

label

Obesity is a significant risk factor for prostate cancer at the time of biopsy.

@ast

Obesity is a significant risk factor for prostate cancer at the time of biopsy.

@en

prefLabel

Obesity is a significant risk factor for prostate cancer at the time of biopsy.

@ast

Obesity is a significant risk factor for prostate cancer at the time of biopsy.

@en

P1433

Q35231117-B50DBD3D-62D5-4596-9FF1-DEB69A0D7F8E

P1476

Q35231117-BC090635-CC4F-4EE3-BA44-A96A0E870333

P2093

Q35231117-170FD4C7-6685-4B1E-A3FF-FB25BD2980C1

Q35231117-38C42366-7D1A-481C-8A4F-98977142D57B

Q35231117-6AB54129-2344-4108-B0B3-805B9A61DC18

Q35231117-98673515-B947-4060-A972-891D347438FF

Q35231117-A639A5A3-9A55-45CD-9D83-4E521D966097

Q35231117-B5DD38FE-A6D8-4069-88C1-69CF3C05B8F0

Q35231117-CEFEC752-0BA2-46A9-B23E-DD6AF1D79B9C

Q35231117-E678EE9A-08AB-4261-AA52-F067DEF6CE6C

P2860

Q35231117-054DEDC1-1F79-42D9-989D-9A0D425AC617

Q35231117-07843D5C-742B-4C28-A458-E54F70F5991A

Q35231117-1039DEE7-14B8-4497-B7AA-6A6E4B8D655A

Q35231117-181610B8-8D05-48A3-8F60-E3230B5B7CC1

Q35231117-1A579DD8-2D33-4038-B27E-5958E761F63D

Q35231117-26270459-773C-4362-AB7A-0DB644E90E48

Q35231117-3207577F-11A6-4F9E-B5BE-C2CAB40205B6

Q35231117-3586AC68-D1FF-41F3-8D5D-074FA1ED70C8

Q35231117-3836B36C-3636-4379-A16A-020A89CD274C

Q35231117-4843B65B-6C46-46C5-A99F-572601353AE7

P304

Q35231117-835C55B0-1115-4235-BA7B-DCBD32B1EF3F

P31

Q35231117-896A93F4-E189-491E-A78B-44694289F970

P356

Q35231117-5F365545-A4F2-4D0E-B1EB-694CA4DEDF43

P407

Q35231117-0C8BF7C1-18A5-43FA-B970-7AEEA089D29F

P433

Q35231117-23DF4BA3-471E-4DAE-B416-84C02921A9AC

P478

Q35231117-37D55934-93B7-428A-9208-14FC25027213

P577

Q35231117-78513E88-E46C-4081-B938-0ABAEBDF0166

P5875

Q35231117-F54A7E1E-F8FD-4DEF-8C15-5CCD5327F3D7

P698

Q35231117-E12F7FF5-5A6C-407F-9E04-1DCF32ADF898

P921

Q35231117-91C9D06F-BCAE-4B0A-B3A1-AD0FB2BF2E26

Q35231117-F79D35ED-D9F3-4F12-ABA2-1746B4702167

P932

Q35231117-76F0B016-5CE0-4EC9-B849-BBF80F2B76A8

P356

J.UROLOGY.2008.05.044

P1433

P1476

Obesity is a significant risk factor for prostate cancer at the time of biopsy.

@en

P2093

Amy Shah

http://www.w3.org/2001/XMLSchema#string

Bita Moalej

http://www.w3.org/2001/XMLSchema#string

Christina Atala

http://www.w3.org/2001/XMLSchema#string

Dominic Lai

http://www.w3.org/2001/XMLSchema#string

Joanne Wen

http://www.w3.org/2001/XMLSchema#string

Melanie Wuerstle

http://www.w3.org/2001/XMLSchema#string

Stephen J Freedland

http://www.w3.org/2001/XMLSchema#string

William J Aronson

http://www.w3.org/2001/XMLSchema#string

P2860

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.

The influence of finasteride on the development of prostate cancer.

Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.

Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.

Body mass index as a predictor of prostate cancer: development versus detection on biopsy.

Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality.

Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program.

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group.

P304

1102-1105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UROLOGY.2008.05.044

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23189519

http://www.w3.org/2001/XMLSchema#string

P698

18722650

http://www.w3.org/2001/XMLSchema#string

P921

P932

3179687

http://www.w3.org/2001/XMLSchema#string